Scott Department of Urology and Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA.
Urology. 2010 Feb;75(2):334-9. doi: 10.1016/j.urology.2009.09.051. Epub 2009 Dec 5.
Bladder cancer (BlCa) is the fifth most common cancer in the United States and one of the ten deadliest. It ranks fifth among all cancers in total costs, consuming almost $3 billion annually, and has an extensive effect on quality of life for survivors and their families. Despite this human and economic toll, BlCa ranks comparatively low on the national agenda. Our understanding of this disease has grown exponentially over the last decade, paving the way for better prevention, detection, treatment, monitoring, and quality of life. Increasing national attention to BlCa is likely to improve disease burden and patient quality of life.
膀胱癌（BlCa）是美国第五大常见癌症，也是十大致命癌症之一。它在总费用方面排名所有癌症中的第五位，每年消耗近 30 亿美元，并且对幸存者及其家庭的生活质量产生广泛影响。尽管造成了人员和经济上的损失，但膀胱癌在国家议程中的排名相对较低。在过去的十年中，我们对这种疾病的认识呈指数级增长，为更好的预防、检测、治疗、监测和提高生活质量铺平了道路。提高对膀胱癌的全国关注度可能会改善疾病负担和患者的生活质量。
